MedPath

The effect of long-term simvastatin treatment on cognitive function and daily life in children with Neurofibromatosis 1: a one year randomized controlled trial

Conditions
eurofibromatosis 1
Registration Number
EUCTR2009-010965-22-NL
Lead Sponsor
Erasmus MC - Department of Pediatrics
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
106
Inclusion Criteria

Inclusion criteria are: age 8 to 16 years, NF1 diagnosis with genetic confirmation, and oral and written informed consent from parents and participants aged older than 12 years.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Exclusion criteria are: segmental NF1, pathology of the CNS (other than asymptomatic gliomas), deafness, severely impaired vision, use of ADHD-medication, use of anti-epileptic drugs, use of simvastatin, use of anti-psychotic medication, insufficient comprehension or production of the Dutch language, and an IQ below 48.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: The primary objective of this study is to determine the effect of long-term simvastatin treatment in NF1 children on cognitive function (IQ) and behavioral problems (both internalizing problems and attention).;Secondary Objective: The secondary objective of this study is to determine the effect of long-term simvastatin treatment in NF1 children on school performance, health related quality of life, behavior (other), cognition (other) and fine motor coordination.;Primary end point(s): Cognitive Function<br>- WISC III-R<br>Behavioral Problems on the Child Behavioral Checklist (CBCL)<br>- Internalizing behavioral problems <br>- Attention problems<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath